Late-Breaking Clinical Trial Submissions – Now Open!

Late-Breaking Clinical Trial Submission Deadline: Wednesday, June 25 2025 – 23:59 CET

Please note: Late-breaking abstract submission, is specifically for Clinical and Ongoing Clinical Trials

Late-breaking clinical trial and Ongoing trial abstracts should contain new, scientifically rigorous information that has not been presented previously in a stroke conference. Results of a clinical trial should likely have a significant impact on clinical practice and/or to make significant advances in the stroke scientific field. Only work that was not available at the time of regular submission should be submitted during the clinical trial late-breaking submission for consideration.

Trials that are completed after the late-breaking submission deadline will be considered, provided that the final results will be available in time for presentation in a plenary or late-breaking session at WSC 2025.

Proposal Submission is now closed.

Proposal Submission Deadline: March 5, 2025 – 23:59 CET

Thank you to everyone who submitted proposals and contributed to shaping the 17th World Stroke Congress in Barcelona. We greatly appreciate your efforts and participation. The committee will now conduct a blind review of all proposals, and those selected to present, will be notified in due course once the program has been finalized.

Prepare your submissions, based on the following topics:

• Artificial Intelligence
• Aneurysm/AVM Intervention
• Awareness
• Basic Science
• Biomarkers
• Cardioembolism
• Cognition and Dementia
• Early (Young) Career
• Epidemiology
• Health Services
• Intracranial Hemorrhage
• Implementation & Knowledge Translation
• Large Artery Disease
• Neurocritical Care
• Neuroimaging
• Nursing
• Outcomes
• Pre-hospital Care
• Prevention
• Rehabilitation and Life After Stroke
• Small Vessel Disease
• Stroke in the Young and Uncommon Etiologies
• Thrombectomy
• Thrombolysis